Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction
24 févr. 2025 17h20 HE
|
Accolade, Inc.
SAN FRANCISCO and SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and...
Transcarent To Acquire Accolade
08 janv. 2025 08h30 HE
|
Accolade, Inc.
Combined company creates industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment Transcarent’s Generative AI WayFinding and care...
Accolade to Announce Fiscal Third Quarter 2025 Financial Results
16 déc. 2024 08h00 HE
|
Accolade, Inc.
SEATTLE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2025 financial results on Thursday, January 9, 2024 after the...
Accolade To Present at Upcoming Investor Conferences
13 nov. 2024 08h00 HE
|
Accolade, Inc.
SEATTLE, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor events. A webcast will be available at...
Accolade Announces Results for Fiscal Second Quarter 2025
08 oct. 2024 07h00 HE
|
Accolade, Inc.
SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2024. “As we enter the second half of...
Accolade to Announce Fiscal Second Quarter 2025 Financial Results
18 sept. 2024 08h00 HE
|
Accolade, Inc.
SEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2025 financial results on Tuesday, October 8, 2024 before market...
Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference
28 août 2024 08h00 HE
|
Accolade, Inc.
SEATTLE, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on...
Accolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
07 août 2024 08h00 HE
|
Accolade, Inc.
SEATTLE, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the Canaccord Genuity 44th Annual Growth Conference & Private Company...
Accolade Announces Results for Fiscal First Quarter 2025
27 juin 2024 16h03 HE
|
Accolade, Inc.
SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy...
Accolade to Announce Fiscal First Quarter 2025 Financial Results
12 juin 2024 08h00 HE
|
Accolade, Inc.
SEATTLE, June 12, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal first quarter 2025 financial results on Thursday, June 27, 2024, after the market...